Samarth Kulkarni, Chief Executive Officer and Director of CRISPR Therapeutics AG (NASDAQ:CRSP), filed a Form 4 on November 19, 2026, disclosing a disposition of 100,000 common shares on November 17, 2026.

Key Highlights

  • Transaction type: 100,000 common shares were disposed of under transaction code "G" (gift) at a price of $0.00.
  • Transaction date: The reported transaction occurred on November 17, 2026.
  • Remaining ownership: Following the transaction, Kulkarni directly holds 211,899 common shares.
  • Reporting person: Samarth Kulkarni is identified as both a Director and Chief Executive Officer of CRISPR Therapeutics AG.
  • No derivative activity: Table II of the filing contains no reported derivative securities transactions.

CEO Samarth Kulkarni Gifts 100,000 Common Shares of CRISPR Therapeutics

According to the Form 4 filed with the U.S. Securities and Exchange Commission on November 19, 2026, Samarth Kulkarni, serving as Chief Executive Officer and Director of CRISPR Therapeutics AG, reported a disposition of 100,000 common shares on November 17, 2026. The filing records the transaction under code "G," indicating a gift, with a stated price of $0.00 per share.

The filing discloses that following this transaction, Kulkarni directly beneficially owns 211,899 common shares of CRISPR Therapeutics AG, listed on NASDAQ under the ticker symbol CRSP. The transaction is recorded as a direct ownership disposition, with no indirect ownership arrangements noted for this transaction. The filing was signed by Samarth Kulkarni on November 19, 2026.

Table II of the filing, covering derivative securities such as options, warrants, or convertible securities, reflects no transactions. The Form 4 was filed by one reporting person and does not indicate that this transaction was made pursuant to a Rule 10b5-1(c) trading plan, as the relevant checkbox on the form is not checked.

What Was Disclosed

The filing reports a single disposition of 100,000 CRISPR Therapeutics AG common shares by CEO Samarth Kulkarni on November 17, 2026, coded as a gift at $0.00, leaving him with direct beneficial ownership of 211,899 shares.